Our cystic fibrosis program began as a small research project in 1998. Today, Vertex has the most CF compounds in clinical development in the industry, and is focused on developing medicines for all people with CF. Learn about our leading role in creating medicines that address the underlying cause of CF.

Learn more about Vertex's CF program

Voices of Vertex

There are approximately 2,000 dedicated Vertex employees working in 15 sites around the world. Each month, we'll be sharing their perspectives about how they are All in for CF.

Voices of Vertex:
Jeff Samels

Jeff Samels, Regional Account Manager and CF Dad

Learn More

Voices of Vertex:<br />Jeff Samels Voices of Vertex:<br />Jeff Samels

Voices of Vertex:
Perspectives

Vertex employees share why they are all in for CF

Learn More

Voices of Vertex:<br />Perspectives

Voices of Vertex:
Paul Negulescu

Voices of Vertex:
Paul Negulescu,
Senior Vice President,
San Diego Research

Learn More

Voices of Vertex: <br/>Paul Negulescu

More employee perspectives will be added monthly. Until then, check out stories from the CF community.

Stories from the CF community

Voices of Vertex:
Brian Bear

Voices of Vertex:
Brian Bear,
Senior Research Scientist,
San Diego Research

Learn More

Voices of Vertex: <br/>Brian Bear

Our Commitment

Vertex initiated its first CF clinical trial in 2006

Learn More

Our Commitment

Vertex & CF: A Timeline

Vertex is committed to advances in cystic fibrosis

Learn More

Vertex & CF: A Timeline

Stay all in with us!

Sign up to receive email updates about All in for CF features and programs

By submitting your e-mail address, you authorize Vertex, its agents, and/or companies working on its behalf to send you updates regarding this website, as well as information about cystic fibrosis and/or Vertex. Vertex will not use your e-mail address for any other purpose, and will not sell, rent, or distribute your e-mail address to any third parties. For more information, review the Vertex Data Privacy Policy.

Thank you for signing up!